MK-0941
Sponsors
Merck Sharp & Dohme LLC
Conditions
Diabetes Mellitus, Non-Insulin-DependentDiabetes Mellitus, Type 2Type 2 DiabetesType 2 Diabetes Mellitus
Phase 1
An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)
CompletedNCT00511472
Start: 2007-07-31End: 2008-04-30Updated: 2015-07-15
MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).
CompletedNCT00754130
Start: 2008-09-30End: 2008-10-31Updated: 2015-03-12
A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)
CompletedNCT00873821
Start: 2008-12-31End: 2009-05-31Updated: 2015-03-09
A Study of Absorption, Metabolism, Excretion and Mass Balance After a Single Dose Administration of MK-0941 (MK-0941-016)(COMPLETED)
CompletedNCT00912002
Start: 2008-10-31End: 2009-01-31Updated: 2015-07-03
Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027)
CompletedNCT01106287
Start: 2009-10-31End: 2010-03-31Updated: 2016-02-04
Phase 2
Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)
TerminatedNCT00767000
Start: 2008-10-31End: 2010-06-30Updated: 2015-02-19
A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)
CompletedNCT00792935
Start: 2009-01-31End: 2010-02-28Updated: 2015-12-17
A Study to Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018)
CompletedNCT00824616
Start: 2009-01-31End: 2010-05-31Updated: 2015-07-28